Market Place
Sourcing Support
All News #Library
Others
Cytovia Presents New Data on CD38-Targeted Flex-NK Bispecific Antibody
09 Dec 2022 //
PRNEWSWIRE
Cytovia Therapeutics Presents Data on CD38-Targeted Flex-NK Bispecific Antibody
09 Dec 2022 //
BIONJ
Cytovia Presents Data on TALEN Gene-Edited iNK Cells and GPC3
07 Nov 2022 //
PRNEWSWIRE
Cytovia To Present New Data on CD38 Flex-NK Cell Engager Bispecific Antibodies
27 Oct 2022 //
PRNEWSWIRE
Cytovia Presents Data for GPC3 Flex-NK Cell Engager Antibody
12 Sep 2022 //
PRNEWSWIRE
Cytovia presents antitumor activity of CD38-Targeting Flex-NK Cell Engager Ab
10 Jun 2022 //
PRNEWSWIRE
Cytovia inks SPAC merger to get NK cell prospects into clinic
27 Apr 2022 //
FIERCEBIOTECH
Cytovia Tx Reports PC Activity of its iNK Cells and Flex-NK Cell Engagers
08 Apr 2022 //
PRNEWSWIRE
Cytovia Therapeutics™ Leadership to Present at Upcoming Conferences
29 Mar 2022 //
GLOBENEWSWIRE
Cytovia Tx`s Data for iPSC-derived NK Cells and Flex-NK Engager Multispecific Ab
16 Mar 2022 //
GLOBENEWSWIRE
Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership
18 Nov 2021 //
GLOBENEWSWIRE
Cytovia Therapeutics Raise $45 Million to Advance NK Cell Therapy Pipeline
13 Sep 2021 //
GLOBENEWSWIRE
Olivier Gouédard joins Cytovia Therapeutics as Chief Operating Officer
22 Jun 2021 //
GLOBENEWSWIRE
Cytovia Partners with National Cancer Institute to Develop Novel Gene
13 Jan 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.